Welcome to our dedicated page for Peraso SEC filings (Ticker: PRSO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Peraso Inc. (NASDAQ: PRSO) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures, drawn from the U.S. Securities and Exchange Commission’s EDGAR system. Peraso is a fabless semiconductor company focused on 60 GHz unlicensed and 5G mmWave wireless technology, and its filings offer detailed insight into its capital structure, governance, financing activities and financial performance.
Investors can review Form 10‑K annual reports and Form 10‑Q quarterly reports to understand how Peraso describes its business, risk factors and results of operations, including its focus on mmWave chipsets, antenna modules, software and IP. These core filings typically include segment information, discussion of fixed wireless access and other applications, and management’s analysis of revenue, expenses and non-GAAP metrics.
Peraso’s frequent Form 8‑K current reports document material events such as earnings releases, strategic review updates, prospectus supplements for at-the-market equity offerings, changes in outstanding securities, and governance matters. For example, 8‑K filings describe the company’s ongoing strategic review and interactions with Mobix Labs, amendments to its Amended and Restated 2019 Stock Incentive Plan, the appointment of director Cees Links, and notices related to regaining compliance with Nasdaq’s minimum bid price requirement.
This page also surfaces registration statements and prospectus supplements that outline Peraso’s at-the-market offering program, as well as disclosures on outstanding warrants, stock options, restricted stock units and the Series A special voting preferred stock. Where available, Form 4 insider transaction reports can be used to track equity transactions by directors and officers.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as changes in capital structure, non-GAAP reconciliations, board and committee changes, and updates on strategic alternatives. Real-time updates ensure that new Peraso filings appear promptly, giving investors an efficient way to follow the company’s regulatory history and ongoing reporting.
Peraso Inc. filed a current report to note that it has issued a new press release updating its ongoing strategic review process. The update also covers developments related to an unsolicited, non-binding proposal from Mobix Labs, Inc., which Peraso had first disclosed on June 27, 2025. The press release dated August 19, 2025 is included as an exhibit and incorporated by reference, indicating that further details on the review and the proposal are contained in that document.
Peraso Inc. received a Schedule 13G/A in which Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report warrants and beneficial ownership rights for Peraso common stock. The filing discloses reported securities to purchase a combined 1,428,570 shares, with reported allocations of 371,424 shares to Iroquois, 1,057,146 shares attributable solely to Mr. Abbe and 371,424 shares attributable to Ms. Page, and shows shared interests of 371,424 shares among the parties.
The filing states the percentages were calculated using 5,027,173 shares outstanding and reports 9.99% for Mr. Abbe and 6.88% for Iroquois and Ms. Page. The reported warrants are subject to a 9.99% blocker, and the cover-page counts reflect shares issuable upon full exercise without applying the blocker, meaning the actual exercisable ownership will be lower. The filers certify these securities were not acquired to change or influence control of the issuer.
Peraso Inc. reported total net revenue of $2.22 million for the quarter and $6.09 million for the six months ended June 30, 2025, with product sales shifting away from discontinued memory ICs toward mmWave ICs and antenna modules. The company recorded a net loss of $1.83 million for the quarter and $2.30 million for the six months, and had cash and cash equivalents of $1.76 million and an accumulated deficit of approximately $179.4 million as of June 30, 2025.
The company completed final end-of-life shipments for its memory ICs in March 2025, reported improved six-month gross profit driven by mmWave product sales, reduced R&D and SG&A costs, and raised proceeds from at-the-market sales. The board has launched a strategic review after receiving an unsolicited, non-binding proposal from Mobix Labs and is pursuing additional financings. Management and the auditor have expressed substantial doubt about the company’s ability to continue as a going concern without additional capital.
Peraso Inc. (PRSO) Chief Technology Officer Alex Tomkins was granted a stock option to purchase 25,000 shares on August 7, 2025 with an exercise price of $0.8399. The option is reported as direct beneficial ownership of 25,000 derivative securities and the filing shows the option price reported as $0.00 in the form's table.
The option vests as to 1/36th of the shares on each monthly anniversary following August 7, 2025. The Form 4 was signed by James Sullivan by power of attorney on August 11, 2025. The filing does not disclose total shares outstanding or the percentage this grant represents, so materiality relative to the company's equity cannot be determined from this Form 4 alone.
James Sullivan, Chief Financial Officer of Peraso Inc. (PRSO), reported acquisition of stock options granting the right to purchase 25,000 shares of common stock at an exercise price of $0.8399 per share, with a transaction date of 08/07/2025. The options vest at 1/36th of the shares on each monthly anniversary following 08/07/2025 and are reported as held directly by the reporting person. The filing lists a date of 08/07/2035 in the date/exercise expiration field and reports total derivative holdings of 25,000 options. The explanation clarifies the monthly vesting schedule and notes that column reporting covers only the listed derivative class.
Brad Lynch, identified in the filing as the Chief Operating Officer of Peraso, Inc. (PRSO), reported receipt of a stock option grant on 08/07/2025. The award comprises 25,000 options to purchase common stock at an exercise price of $0.8399, with a stated expiration of 08/07/2035.
The option vests monthly at 1/36th of the shares following the grant date, the acquisition is reported as an “A” (acquired) transaction, and the filing shows 25,000 derivative securities beneficially owned following the transaction, held in a direct ownership form. The Form 4 was filed by one reporting person and includes explanatory notes on vesting and reporting conventions.
Peraso Inc. insider grant: Ronald Glibbery, who is listed as both Chief Executive Officer and a director of Peraso Inc. (PRSO), was granted a stock option on 08/07/2025 to buy 25,000 shares of common stock at an exercise price of $0.8399 per share. The option vests in 36 equal monthly installments (1/36th on each monthly anniversary beginning August 7, 2025) and the reported expiration date is August 7, 2035. The filing reports the options as directly beneficially owned by Mr. Glibbery and shows 25,000 derivative securities of this class following the transaction. No other non-derivative transactions are reported in this Form 4.
Peraso Inc. furnished a press release reporting its financial results for the three and six months ended June 30, 2025 and provided reconciliations of non‑GAAP measures in Exhibit 99.1.
Management presents non‑GAAP measures that exclude stock‑based compensation, amortization of intangibles (none recorded for the periods because intangibles were fully amortized as of December 31, 2024), severance costs (related to employee reductions begun in November 2023; severance amounts were fully paid in July 2025), and changes in fair value of warrant liabilities (from warrants issued in November 2022 and June 2023). The company defines adjusted EBITDA as GAAP net income (loss) excluding those items plus interest, depreciation and taxes. Reconciliations to the most directly comparable GAAP measures are furnished in the press release. The filing notes these materials are furnished, not "filed," for Section 18 purposes.